ID   AATM_HUMAN              Reviewed;         430 AA.
AC   P00505; B4DJA6; E7ERW2; Q53FL3; Q9BWA3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Aspartate aminotransferase, mitochondrial;
DE            Short=mAspAT;
DE            EC=2.6.1.1;
DE            EC=2.6.1.7;
DE   AltName: Full=Fatty acid-binding protein;
DE            Short=FABP-1;
DE   AltName: Full=Glutamate oxaloacetate transaminase 2;
DE   AltName: Full=Kynurenine aminotransferase 4;
DE   AltName: Full=Kynurenine aminotransferase IV;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase 4;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase IV;
DE   AltName: Full=Plasma membrane-associated fatty acid-binding protein;
DE            Short=FABPpm;
DE   AltName: Full=Transaminase A;
DE   Flags: Precursor;
GN   Name=GOT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-346.
RX   PubMed=3207426; DOI=10.1016/S0006-291X(88)81017-9;
RA   Pol S., Bousquet-Lemercier B., Pave-Preux M., Pawlak A., Nalpas B.,
RA   Berthelot P., Hanoune J., Barouki R.;
RT   "Nucleotide sequence and tissue distribution of the human
RT   mitochondrial aspartate aminotransferase mRNA.";
RL   Biochem. Biophys. Res. Commun. 157:1309-1315(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLY-346.
RC   TISSUE=Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-428.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 30-430, AND VARIANT GLY-346.
RX   PubMed=4052435; DOI=10.1016/0167-4838(85)90172-4;
RA   Martini F., Angelaccio S., Barra D., Pascarella S., Maras B.,
RA   Doonan S., Bossa F.;
RT   "The primary structure of mitochondrial aspartate aminotransferase
RT   from human heart.";
RL   Biochim. Biophys. Acta 832:46-51(1985).
RN   [7]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9537447; DOI=10.1002/hep.510270423;
RA   Zhou S.L., Gordon R.E., Bradbury M., Stump D., Kiang C.L., Berk P.D.;
RT   "Ethanol up-regulates fatty acid uptake and plasma membrane expression
RT   and export of mitochondrial aspartate aminotransferase in HepG2
RT   cells.";
RL   Hepatology 27:1064-1074(1998).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73; LYS-90; LYS-159;
RP   LYS-234; LYS-296; LYS-396 AND LYS-404, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND THR-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-48; TYR-96; SER-143 AND
RP   THR-333, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-29, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the irreversible transamination of the L-
CC       tryptophan metabolite L-kynurenine to form kynurenic acid (KA).
CC       Plays a key role in amino acid metabolism. Important for
CC       metabolite exchange between mitochondria and cytosol. Facilitates
CC       cellular uptake of long-chain free fatty acids.
CC       {ECO:0000269|PubMed:9537447}.
CC   -!- CATALYTIC ACTIVITY: L-aspartate + 2-oxoglutarate = oxaloacetate +
CC       L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + 2-oxoglutarate = 4-(2-
CC       aminophenyl)-2,4-dioxobutanoate + L-glutamate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:9537447}. Cell membrane
CC       {ECO:0000269|PubMed:9537447}. Note=Exposure to alcohol promotes
CC       translocation to the cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P00505-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P00505-2; Sequence=VSP_054848;
CC   -!- INDUCTION: Up-regulated by long-time exposure to alcohol.
CC       {ECO:0000269|PubMed:9537447}.
CC   -!- MISCELLANEOUS: In eukaryotes there are cytoplasmic, mitochondrial
CC       and chloroplastic isozymes.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22632; AAA35568.1; -; mRNA.
DR   EMBL; AK295993; BAG58768.1; -; mRNA.
DR   EMBL; AK223271; BAD96991.1; -; mRNA.
DR   EMBL; AC012183; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000525; AAH00525.1; -; mRNA.
DR   CCDS; CCDS10801.1; -. [P00505-1]
DR   CCDS; CCDS67045.1; -. [P00505-2]
DR   PIR; A31873; XNHUDM.
DR   RefSeq; NP_001273149.1; NM_001286220.1. [P00505-2]
DR   RefSeq; NP_002071.2; NM_002080.3. [P00505-1]
DR   UniGene; Hs.599470; -.
DR   PDB; 5AX8; X-ray; 2.99 A; A/B/C/D=30-430.
DR   PDBsum; 5AX8; -.
DR   ProteinModelPortal; P00505; -.
DR   SMR; P00505; -.
DR   BioGrid; 109068; 22.
DR   IntAct; P00505; 8.
DR   MINT; MINT-1406848; -.
DR   STRING; 9606.ENSP00000245206; -.
DR   DrugBank; DB02783; 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   TCDB; 9.A.70.1.1; the aspartate amino transferase (aat) family.
DR   iPTMnet; P00505; -.
DR   PhosphoSitePlus; P00505; -.
DR   SwissPalm; P00505; -.
DR   BioMuta; GOT2; -.
DR   DMDM; 308153643; -.
DR   UCD-2DPAGE; P00505; -.
DR   EPD; P00505; -.
DR   MaxQB; P00505; -.
DR   PaxDb; P00505; -.
DR   PeptideAtlas; P00505; -.
DR   PRIDE; P00505; -.
DR   TopDownProteomics; P00505-1; -. [P00505-1]
DR   DNASU; 2806; -.
DR   Ensembl; ENST00000245206; ENSP00000245206; ENSG00000125166. [P00505-1]
DR   Ensembl; ENST00000434819; ENSP00000394100; ENSG00000125166. [P00505-2]
DR   GeneID; 2806; -.
DR   KEGG; hsa:2806; -.
DR   UCSC; uc002eof.2; human. [P00505-1]
DR   CTD; 2806; -.
DR   DisGeNET; 2806; -.
DR   GeneCards; GOT2; -.
DR   H-InvDB; HIX0013095; -.
DR   HGNC; HGNC:4433; GOT2.
DR   HPA; HPA018139; -.
DR   MIM; 138150; gene.
DR   neXtProt; NX_P00505; -.
DR   OpenTargets; ENSG00000125166; -.
DR   PharmGKB; PA28818; -.
DR   eggNOG; KOG1411; Eukaryota.
DR   eggNOG; COG1448; LUCA.
DR   GeneTree; ENSGT00390000014081; -.
DR   HOGENOM; HOG000185898; -.
DR   HOVERGEN; HBG000951; -.
DR   InParanoid; P00505; -.
DR   KO; K14455; -.
DR   OMA; WANHAAV; -.
DR   OrthoDB; EOG091G06G3; -.
DR   PhylomeDB; P00505; -.
DR   TreeFam; TF300641; -.
DR   BioCyc; MetaCyc:HS04858-MONOMER; -.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   ChiTaRS; GOT2; human.
DR   GeneWiki; GOT2; -.
DR   GenomeRNAi; 2806; -.
DR   PRO; PR:P00505; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000125166; -.
DR   CleanEx; HS_GOT2; -.
DR   ExpressionAtlas; P00505; baseline and differential.
DR   Genevisible; P00505; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004069; F:L-aspartate:2-oxoglutarate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0080130; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005543; F:phospholipid binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB.
DR   GO; GO:0019470; P:4-hydroxyproline catabolic process; TAS:BHF-UCL.
DR   GO; GO:0006532; P:aspartate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006533; P:aspartate catabolic process; IDA:UniProtKB.
DR   GO; GO:0006531; P:aspartate metabolic process; ISS:UniProtKB.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0015908; P:fatty acid transport; IEP:UniProtKB.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0019551; P:glutamate catabolic process to 2-oxoglutarate; IEA:Ensembl.
DR   GO; GO:0019550; P:glutamate catabolic process to aspartate; IEA:Ensembl.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IDA:UniProtKB.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR000796; Asp_trans.
DR   InterPro; IPR004838; NHTrfase_class1_PyrdxlP-BS.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR11879; PTHR11879; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   PRINTS; PR00799; TRANSAMINASE.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminotransferase;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Lipid transport; Membrane; Methylation; Mitochondrion; Nitration;
KW   Phosphoprotein; Polymorphism; Pyridoxal phosphate; Reference proteome;
KW   Transferase; Transit peptide; Transport.
FT   TRANSIT       1     29       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:4052435}.
FT   CHAIN        30    430       Aspartate aminotransferase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000001215.
FT   BINDING      65     65       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     162    162       Substrate. {ECO:0000250}.
FT   BINDING     215    215       Substrate. {ECO:0000250}.
FT   BINDING     407    407       Substrate. {ECO:0000250}.
FT   MOD_RES      48     48       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      59     59       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES      73     73       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      73     73       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES      82     82       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES      90     90       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      90     90       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES      96     96       Nitrated tyrosine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES      96     96       Phosphotyrosine; alternate.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     107    107       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     107    107       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     122    122       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     122    122       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     159    159       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     159    159       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     185    185       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     185    185       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     227    227       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     234    234       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     279    279       N6-(pyridoxal phosphate)lysine;
FT                                alternate. {ECO:0000250}.
FT   MOD_RES     279    279       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     296    296       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     296    296       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     302    302       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     309    309       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     309    309       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P12344}.
FT   MOD_RES     313    313       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     333    333       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     338    338       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     338    338       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     345    345       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     363    363       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     363    363       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     364    364       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     387    387       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     396    396       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     396    396       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   MOD_RES     404    404       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     404    404       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P05202}.
FT   VAR_SEQ      83    125       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054848.
FT   VARIANT       2      2       A -> S (in dbSNP:rs11558171).
FT                                /FTId=VAR_055494.
FT   VARIANT     188    188       G -> S (in dbSNP:rs11076256).
FT                                /FTId=VAR_031710.
FT   VARIANT     346    346       V -> G (in dbSNP:rs30842).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:3207426,
FT                                ECO:0000269|PubMed:4052435}.
FT                                /FTId=VAR_031711.
FT   VARIANT     428    428       V -> A (in dbSNP:rs17849335).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031712.
FT   CONFLICT    110    111       AE -> EA (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       D -> N (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    258    258       A -> T (in Ref. 3; BAD96991).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       E -> Q (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        43     53       {ECO:0000244|PDB:5AX8}.
FT   HELIX        78     88       {ECO:0000244|PDB:5AX8}.
FT   TURN         89     91       {ECO:0000244|PDB:5AX8}.
FT   HELIX       103    114       {ECO:0000244|PDB:5AX8}.
FT   HELIX       119    123       {ECO:0000244|PDB:5AX8}.
FT   STRAND      126    132       {ECO:0000244|PDB:5AX8}.
FT   HELIX       133    148       {ECO:0000244|PDB:5AX8}.
FT   STRAND      153    159       {ECO:0000244|PDB:5AX8}.
FT   HELIX       165    172       {ECO:0000244|PDB:5AX8}.
FT   STRAND      175    180       {ECO:0000244|PDB:5AX8}.
FT   TURN        184    187       {ECO:0000244|PDB:5AX8}.
FT   HELIX       191    198       {ECO:0000244|PDB:5AX8}.
FT   STRAND      206    213       {ECO:0000244|PDB:5AX8}.
FT   HELIX       223    236       {ECO:0000244|PDB:5AX8}.
FT   STRAND      239    246       {ECO:0000244|PDB:5AX8}.
FT   TURN        247    251       {ECO:0000244|PDB:5AX8}.
FT   HELIX       254    257       {ECO:0000244|PDB:5AX8}.
FT   HELIX       259    266       {ECO:0000244|PDB:5AX8}.
FT   STRAND      272    276       {ECO:0000244|PDB:5AX8}.
FT   TURN        278    280       {ECO:0000244|PDB:5AX8}.
FT   TURN        284    287       {ECO:0000244|PDB:5AX8}.
FT   STRAND      288    294       {ECO:0000244|PDB:5AX8}.
FT   HELIX       298    315       {ECO:0000244|PDB:5AX8}.
FT   STRAND      316    318       {ECO:0000244|PDB:5AX8}.
FT   HELIX       321    332       {ECO:0000244|PDB:5AX8}.
FT   HELIX       334    364       {ECO:0000244|PDB:5AX8}.
FT   HELIX       372    376       {ECO:0000244|PDB:5AX8}.
FT   STRAND      379    383       {ECO:0000244|PDB:5AX8}.
FT   HELIX       388    398       {ECO:0000244|PDB:5AX8}.
FT   STRAND      406    409       {ECO:0000244|PDB:5AX8}.
FT   HELIX       410    412       {ECO:0000244|PDB:5AX8}.
FT   HELIX       415    428       {ECO:0000244|PDB:5AX8}.
SQ   SEQUENCE   430 AA;  47518 MW;  F559567ABF2DB346 CRC64;
     MALLHSGRVL PGIAAAFHPG LAAAASARAS SWWTHVEMGP PDPILGVTEA FKRDTNSKKM
     NLGVGAYRDD NGKPYVLPSV RKAEAQIAAK NLDKEYLPIG GLAEFCKASA ELALGENSEV
     LKSGRFVTVQ TISGTGALRI GASFLQRFFK FSRDVFLPKP TWGNHTPIFR DAGMQLQGYR
     YYDPKTCGFD FTGAVEDISK IPEQSVLLLH ACAHNPTGVD PRPEQWKEIA TVVKKRNLFA
     FFDMAYQGFA SGDGDKDAWA VRHFIEQGIN VCLCQSYAKN MGLYGERVGA FTMVCKDADE
     AKRVESQLKI LIRPMYSNPP LNGARIAAAI LNTPDLRKQW LQEVKVMADR IIGMRTQLVS
     NLKKEGSTHN WQHITDQIGM FCFTGLKPEQ VERLIKEFSI YMTKDGRISV AGVTSSNVGY
     LAHAIHQVTK
//
